Clinical trial
Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue…
NCT00446901 · Wageningen University, Other · Completed
Key facts
| NCT number | NCT00446901 |
|---|---|
| Title | Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression |
| Official title | Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression |
| Acronym | SePros |
| Lead sponsor | Wageningen University, Other |
| Collaborators | World Cancer Research Fund International |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms, Prostate Cancer |
| Intervention type | Dietary Supplement |
| Interventions | Selenium |
| Enrollment | 60 |
| Start date | Jun 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Mar 13, 2007 |
| Last update posted | Mar 14, 2011 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: